1. Home
  2. SABS vs MXC Comparison

SABS vs MXC Comparison

Compare SABS & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • MXC
  • Stock Information
  • Founded
  • SABS 2014
  • MXC 1972
  • Country
  • SABS United States
  • MXC United States
  • Employees
  • SABS N/A
  • MXC N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • SABS Health Care
  • MXC Energy
  • Exchange
  • SABS Nasdaq
  • MXC Nasdaq
  • Market Cap
  • SABS 15.8M
  • MXC 18.4M
  • IPO Year
  • SABS N/A
  • MXC N/A
  • Fundamental
  • Price
  • SABS $2.35
  • MXC N/A
  • Analyst Decision
  • SABS Strong Buy
  • MXC
  • Analyst Count
  • SABS 4
  • MXC 0
  • Target Price
  • SABS $9.50
  • MXC N/A
  • AVG Volume (30 Days)
  • SABS 427.8K
  • MXC 4.1K
  • Earning Date
  • SABS 11-05-2025
  • MXC 11-06-2025
  • Dividend Yield
  • SABS N/A
  • MXC 1.08%
  • EPS Growth
  • SABS N/A
  • MXC 44.21
  • EPS
  • SABS N/A
  • MXC 0.79
  • Revenue
  • SABS $114,698.00
  • MXC $7,444,407.00
  • Revenue This Year
  • SABS N/A
  • MXC N/A
  • Revenue Next Year
  • SABS N/A
  • MXC N/A
  • P/E Ratio
  • SABS N/A
  • MXC $11.39
  • Revenue Growth
  • SABS N/A
  • MXC 13.06
  • 52 Week Low
  • SABS $1.00
  • MXC $5.89
  • 52 Week High
  • SABS $6.60
  • MXC $16.00
  • Technical
  • Relative Strength Index (RSI)
  • SABS 54.67
  • MXC 59.19
  • Support Level
  • SABS $2.20
  • MXC $8.84
  • Resistance Level
  • SABS $2.60
  • MXC $9.46
  • Average True Range (ATR)
  • SABS 0.19
  • MXC 0.38
  • MACD
  • SABS 0.02
  • MXC -0.02
  • Stochastic Oscillator
  • SABS 68.00
  • MXC 73.37

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: